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Rett syndrome (RS) causes severe cognitive impairment, loss of speech, epilepsy, and
breathing disturbances with intermittent hypoxia. Also mitochondria are affected; a subunit
of respiratory complex III is dysregulated, the inner mitochondrial membrane is leaking
protons, and brain ATP levels seem reduced. Our recent assessment of mitochondrial func-
tion in MeCP2 (methyl-CpG-binding protein 2)-deﬁcient mouse (Mecp2−/y ) hippocampus
conﬁrmed earlymetabolic alterations, an increased oxidative burden, and amore vulnerable
cellular redox balance. As these changes may contribute to the manifestation of symptoms
and disease progression, we now evaluated whether free radical scavengers are capable
of improving neuronal and mitochondrial function in RS. Acute hippocampal slices of adult
mice were incubated with the vitamin E derivativeTrolox for 3–5 h. In Mecp2−/y slices this
treatment dampened neuronal hyperexcitability, improved synaptic short-term plasticity,
and fully restored synaptic long-term potentiation (LTP). Furthermore, Trolox speciﬁcally
attenuated the increased hypoxia susceptibility of Mecp2−/y slices. Also, the anticon-
vulsive effects of Trolox were assessed, but the severity of 4-aminopyridine provoked
seizure-like discharges was not signiﬁcantly affected. Adverse side effects of Trolox on
mitochondria can be excluded, but clear indications for an improvement of mitochondrial
function were not found. Since several ion-channels and neurotransmitter receptors are
redox modulated, the mitochondrial alterations and the associated oxidative burden may
contribute to the neuronal dysfunction in RS. We conﬁrmed in Mecp2−/y hippocampus
thatTrolox dampens neuronal hyperexcitability, reinstates synaptic plasticity, and improves
the hypoxia tolerance. Therefore, radical scavengers are promising compounds for the
treatment of neuronal dysfunction in RS and deserve further detailed evaluation.
Keywords: oxidative stress, redox signaling, reactive oxygen species (ROS), mitochondrial metabolism, free radical
scavenger, neurodevelopmental disorder, synaptic dysfunction, vitamin E
INTRODUCTION
Rett syndrome (RS) is a neurodevelopmental disorder that almost
exclusively affects girls. It arises from spontaneous mutations in
an X-chromosomal gene encoding the transcriptional modula-
tor MeCP2 (methyl-CpG-binding protein 2; Hagberg et al., 1983;
Amir et al., 1999; Chahrour et al., 2008) and is associated with
severe disabilities. In RS, an initially normal development for
the ﬁrst 6–18 months of life is followed by motor dysfunction,
cognitive impairment, loss of speech, epilepsy, and severe breath-
ing disturbances with intermittent systemic hypoxia (Hagberg
et al., 1983; Julu et al., 2001; Steffenburg et al., 2001; Percy, 2002;
Chahrour and Zoghbi, 2007; Stettner et al., 2008; Katz et al., 2009).
These symptoms result from an impaired synaptic maturation and
plasticity as well as a general dysfunction of MeCP2-deﬁcient neu-
ronal networks. Yet, despite the severity of symptoms, pronounced
neurodegeneration does not occur in RS (Armstrong et al., 1995;
Guy et al., 2007).
There is substantial evidence that also mitochondria are
impaired in RS. Typical morphological alterations of mitochon-
dria are membrane changes, granular inclusions, vacuolizations,
and a swollen appearance (Ruch et al., 1989; Eeg-Olofsson et al.,
1990; Cornford et al., 1994; Belichenko et al., 2009). Alterations
of mitochondrial function include decreased levels of succinate-
cytochrome c reductase and cytochrome c oxidase, a proton leak
across the inner mitochondrial membrane, and a reduced respi-
ratory capacity (Coker and Melnyk, 1991; Kriaucionis et al., 2006;
Gibson et al., 2010; Li et al., 2013). Furthermore, lowered blood
serum levels of vitamin E (Formichi et al., 1998) and a reduced
activity of the reactive oxygen species (ROS)-detoxifying enzyme
superoxide dismutase (SOD) are evident (Sierra et al., 2001). These
deﬁciencies in cellular ROS-scavenging capabilities combinedwith
impaired mitochondrial function could well contribute to the
intensiﬁedprotein- and lipid-oxidation that is detectable in patient
blood samples (Sierra et al., 2001; De Felice et al., 2009), and which
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provided convincing evidence that RS is associated with oxidative
stress [see: (De Felice et al., 2012b)].
Following these indications we have recently analyzed mito-
chondrial function in the hippocampus of male Mecp2 knock-out
mice (Mecp2−/y). In acute tissue slices of adult mice we conﬁrmed
an increased basal mitochondrial respiration and less intensely
polarized mitochondria. As mitochondrial respiration is already
intensiﬁed after the 1st postnatal week, these alterations represent
early defects in RS that may facilitate disease progression (Großer
et al., 2012). Using the genetically encoded optical redox sensor
roGFP1 (Dooley et al., 2004; Hanson et al., 2004; Funke et al.,
2011),we also conﬁrmed amore oxidized andmore vulnerable cel-
lular redox balance in neonatal Mecp2−/y hippocampus (Großer
et al., 2012). Furthermore, incubating organotypic slices with
the radical scavenger Trolox improved cellular redox conditions,
which identiﬁes radical scavenger treatment as a potential phar-
macotherapy in RS. This is also supported by a report that a diet
rich in ω-3 polyunsaturated fatty acids successfully decreases the
severity of the clinical appearance and lowers the levels of various
oxidative stress markers in Rett patients (De Felice et al., 2012a).
It is therefore tempting to hypothesize that the chronic oxidative
stress in RS underlies at least some of the typical symptoms and
contributes to disease progression.
In the present study, we therefore evaluated the pharmacother-
apeutic potential of the radical scavenger Trolox, a water soluble
vitamin E derivative, in RS. Vitamin E and its derivatives pre-
vent the peroxidation of unsaturated lipids in cell membranes
and lipoproteins (Wang and Quinn, 1999; Slemmer et al., 2008).
Since vitamin E levels are decreased in the blood serum of Rett
patients (Formichi et al., 1998), supplementation with vitamin E
and/or its derivatives is a logical approach. In detail, we eluci-
dated the potential merit of Trolox in acute hippocampal tissue
slices of adult wildtype (WT) and Mecp2−/y mice. Our focus was
on a potential improvement of synaptic function and plasticity,
hypoxia tolerance, and mitochondrial function in the tissue of
already symptomatic animals. For several of the tested param-
eters, which are affected in RS, we found an improvement –
often to those conditions typical for WT mice. We therefore
conclude that radical scavenger treatment is a promising phar-




As a mouse model for RS, we continued to use mice lacking the
MECP2 gene [B6.129P2(C)-Mecp2tm−1−1Bird (Guy et al., 2001)].
Heterozygous female mice were obtained from Jackson Laborato-
ries and bred withWT males (C57BL/6J) to generate heterozygous
females, hemizygous males, and WT mice of either gender. All
experiments were performed on acute tissue slices obtained from
adult hemizygous males (Mecp2−/y) around postnatal day 40–
50. At this stage, all Mecp2−/y animals showed characteristic RS
symptoms, including a ∼40% reduction in body weight, smaller
brain size, low motor activity, very frequent hind-limb clasping,
obvious breathing disturbances (Guy et al., 2001), as well as fre-
quent seizures during anesthesia. Onlymalemicewere used for the
experiments due their earlier and more severe phenotype and in
particular to ensure a consistent and complete MeCP2-deﬁciency
in the analyzed brain tissue.
Deeply ether anesthetized mice were decapitated, the brain
was rapidly removed from the skull and placed in chilled arti-
ﬁcial cerebrospinal ﬂuid (ACSF) for 1–2 min. Acute neocorti-
cal/hippocampal tissue slices (400 μm thick transverse slices) were
cut from the forebrain using a vibroslicer (Campden Instruments,
752M Vibroslice). The slices were then separated in the sagittal
midline and depending on the very type of experiment they were
either directly transferred to an interface recording chamber or to
a separate submersion-style storage chamber. In any case, slices
were left undisturbed for at least 90 min before the experiments
were started.
SOLUTIONS
All chemicals were obtained from Sigma–Aldrich, unless stated
otherwise. ACSF was composed of (in mM): 130 NaCl, 3.5 KCl,
1.25 NaH2PO4, 24 NaHCO3, 1.2 CaCl2, 1.2 MgSO4, and 10 dex-
trose; it was aerated constantly with 95% O2 - 5% CO2 (carbogen)
to adjust pH to 7.4. The free radical scavenger Trolox [(+/−)-6-
hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid] and the
convulsant 4-aminopyridine (4-AP) were directly added to the
ACSF in their ﬁnal concentrations. Cyanide (CN−, sodium salt)
was dissolved as an aqueous 1 M stock solution and stored at
−20◦C; CN− working dilutions were prepared freshly immedi-
ately before use. FCCP [carbonyl cyanide 4-(triﬂuoromethoxy)
phenylhydrazone, Tocris] and Rh123 were dissolved in dimethyl
sulfoxide (DMSO) as 10 mM and 20 mg/ml stocks, respec-
tively, and stored at 4◦C; ﬁnal DMSO concentrations were
≤0.05%.
HYPOXIA PROTOCOL AND ELECTROPHYSIOLOGICAL RECORDINGS
Electrophysiological recordings were performed in an Oslo style
interface recording chamber. It was kept at a temperature of either
31−32◦C (synaptic function and plasticity) or 35−36◦C (hypoxia
and seizures), continuously aerated with carbogen (400 ml/min),
and perfused with oxygenatedACSF (3-4 ml/min). Severe hypoxia
was induced by switching the recording chamber’s gas supply
from carbogen to 95% N2 − 5% CO2 (carbogen aeration of the
ACSF was continued), and it triggered hypoxia-induced spread-
ing depression (HSD) -like depolarizations within a few minutes.
O2 was resubmitted 30 s after the onset of HSD, within that time
the extracellular DC potential shift had fully reached its nadir.
Extracellular recording electrodes were pulled from thin-walled
borosilicate glass (GC150TF-10, Harvard Apparatus) on a hori-
zontal electrode puller (Model P-97, Sutter Instruments). They
were ﬁlled with ACSF, and their tips were trimmed to a resistance
of ∼5 M.
Field excitatory postsynaptic potentials (fEPSPs) were elicited
by 0.1 ms unipolar stimuli (S88 stimulator with PSIU6 stimu-
lus isolation units, Grass Instruments), and delivered via steel
microwire electrodes (50 μm diameter, AM-Systems) to the
Schaffer collaterals. The resulting orthodromic responses and the
extracellular DC potential shifts associated with HSD were mea-
sured in st. radiatum of the cornu ammonis 1 (CA1) subﬁeld.
Seizure-like events (SLEs) were monitored in st. pyramidale of
the CA3 region. All electrophysiological data were recorded with
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a locally constructed extracellular DC potential ampliﬁer (Hepp
et al., 2005) and sampled using an Axon Instruments Digitizer
1322A and PClamp 9.2 software (Molecular Devices). HSD was
sampled at 2.5 kHz, evoked potentials and SLEs were sampled at
20 kHz.
Synaptic plasticity was analyzed by paired-pulse protocols and
LTP-inducing protocols. For paired-pulse facilitation (PPF), stim-
ulus intensitywas adjusted to obtain half-maximumresponses and
the inter-stimulus interval was varied in between 25 and 200 ms.
LTP was induced in the presence of normal extracellular Ca2+
concentration (1.2 mM) by applying stimuli of corresponding
intensity at a rate of 100 Hz. These stimuli were delivered in three
trains of 1 s duration each and separated by 5 min intervals.
OPTICAL RECORDINGS
Imaging of ﬂavin adenine dinucleotide (FAD) and nicotinamide
adenine dinucleotide (NADH) autoﬂuorescence as well as mito-
chondrial membrane potential (m) was performed on the
tissue level, using a computer-controlled digital imaging system. It
was composedof a polychromatic xenon-light source (Polychrome
II, Till Photonics) and a sensitive CCD camera (Imago QE, PCO
Imaging). This camera type is equipped with a 2/3 inch CCD chip
(1376×1040 pixels; 6.45 μm × 6.45 μm on chip pixel size), and it
exhibits a 62% quantum efﬁciency at 500 nm.
For the imaging of slices a submersion-style chamber
(30−32◦C) and a 40x water immersion objective (Zeiss Achro-
plan, 0.8 NA) were used; the slices were kept in place by a
nylon-wired platinum grid. To rate mitochondrial metabolism,
FAD and NADH autoﬂuorescence were monitored in a ratiomet-
ric approach by alternate excitation at 445 nm (FAD) and 360 nm
(NADH); autoﬂuorescence was recorded using a 450 nm beam-
splitter and a 510/80 nm bandpass ﬁlter (Duchen and Biscoe,
1992; Foster et al., 2006; Gerich et al., 2006). 4×4 pixel bin-
ning was applied to increase the detection sensitivity of the CCD
camera. Rh123, a marker of m (Emaus et al., 1986; Duchen,
1999; Foster et al., 2006), was excited at 480 nm and its emis-
sion was recorded in 2×2 pixel binning mode, using a 505 nm
beam-splitter and a 535/35 nm bandpass ﬁlter. Slices were bulk
loaded with Rh123 (5 μM, 15 min) in a miniaturized staining
chamber (Funke et al., 2007; Großer et al., 2012). Rh123 was
used in quenching mode. Accordingly, mitochondrial depolar-
ization is indicated by an increase in Rh123 ﬂuorescence due
to its release from mitochondria into the cytosol. To minimize
the risk of phototoxicity that may arise especially from short-
wavelength (near-UV) illumination, the imaging experiments –
which in part lasted up to 1 h – were performed at low frames
rates, acquiring images every 5 s only. Furthermore, the illumina-
tion was minimized to those exposure times yielding sufﬁciently
stable CCD camera readings (NADH 70 ms, FAD 40 ms, Rh123
5 ms).
Fluorescence intensities were averaged within deﬁned regions
of interest (size ∼50 × 50 μm) placed in the middle of st.
radiatum (see Figure 4D), since synaptic function was charac-
terized in this layer as well. The intensity changes observed were
referred to pre-treatment baselines; background correction was
not performed. As intended by this approach, all optical anal-
yses yield information from a tissue volume rather than single
cells and thus represent a mixed signal from neurons and glia.
Cellular boundaries or organelle structures could not be identi-
ﬁed in the low-magniﬁcation epiﬂuorescence recordings of tissue
autoﬂuorescence or tissue Rh123 ﬂuorescence.
STATISTICS
Since the electrophysiological and optical experiments lasted only
∼1 h, we used up to six slices from each brain. Nevertheless,
to ensure independence of observations, every series of experi-
ments was run on at least four different mice of each genotype.
All numerical values are reported as mean ± standard devia-
tion; the number of experiments (n) refers to the number of
slices analyzed. Statistical signiﬁcance of the changes observed
was tested by two-tailed, unpaired Student’s t-tests and a signiﬁ-
cance level of P = 0.05. In the diagrams, statistically signiﬁcant
changes are indicated by asterisks (∗P < 0.05; ∗∗P < 0.01;
∗∗∗P < 0.001), and the corresponding P values are reported in the
text.
RESULTS
To rate thepotentialmerits of a treatment of MeCP2-deﬁcient neu-
ronal networks with free radical scavengers, we preincubated acute
hippocampal tissue slices of adult WT and Mecp2−/y mice with
1 mM Trolox for at least 3 h (range 3–5 h). The effects on synap-
tic function and synaptic plasticity, neuronal excitability, hypoxia
susceptibility as well as mitochondrial function were then assessed
in the continued presence of Trolox. To be able to screen for a
potential reversal of typical RS symptoms, these analyses were
performed at an age, at which male Rett mice already show clear
phenotypic symptoms, i.e., around postnatal day p40–50.
MODULATION OF NEURONAL EXCITABILITY AND SYNAPTIC FUNCTION
Basal synaptic function was rated based on the recording of
orthodromically evoked excitatory ﬁeld potentials (fEPSP) in st.
radiatum of theCA1 subﬁeld. The fEPSP amplitudes were normal-
ized to the ﬁber volley (presynaptic compound action potential) to
account for differences among the individual slices and variations
in electrode positioning. Under control conditions, Mecp2−/y
slices (n = 37) showed signiﬁcantly (∼44%) higher fEPSP/ﬁber
volley ratios than WT slices (n = 50) at all stimulation intensities
tested, which indicates an increased postsynaptic responsiveness
and neuronal hyperexcitability (Figure 1A). The ﬁber volley itself
and the general shape of the input–output curves did, however,
not differ among genotypes; neither could multiple population
spikes as a clear sign of pronounced hyperexcitability be observed
on a regular basis.
Trolox treatment of slices (1 mM, 3–5 h) abolished the
genotypic differences in fEPSP/ﬁber volley ratios, by speciﬁcally
decreasing the responses in Mecp2−/y slices (n = 43) to those lev-
els observed in untreated and treated WT slices. Obvious changes
in the shape of the input-output curves were not observed upon
Trolox treatment (Figure 1A). In WT, Trolox did not induce any
signiﬁcant changes in the fEPSP/ﬁber volley ratio (n = 44).
Synaptic plasticity is markedly impaired in Rett mice (Asaka
et al., 2006; Moretti et al., 2006; Guy et al., 2007; Fischer et al.,
2009). Therefore, we also analyzed the effects of Trolox on
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FIGURE 1 |Trolox dampens neuronal hyperexcitability and reinstates
LTP in Mecp2−/y hippocampus. (A) Input-output curves showing a
signiﬁcantly increased excitability in Mecp2−/y slices as compared to WT
at all stimulation intensities (10–20 μA P < 0.05; 30–60 μA P < 0.01,
70–150 μA P < 0.001). Trolox (1 mM, 3–5h) abolished this genotypic
difference. The plotted fEPSP amplitudes are normalized to the ﬁber volley
of the respective slice. Displayed are the averages of 37–50 slices, and
error bars represent standard deviations; for clarity they are shown for
Mecp2−/y and Mecp2−/y plus Trolox only. (B) Paired-pulse facilitation
(PPF), a measure of short-term plasticity, was less pronounced in
Mecp2−/y than in WT slices for the shortest interpulse-interval tested.
Trolox abolished this genotypic difference, but otherwise did not mediate
any noticeable effects. Plotted are the averages of 35–52 slices; asterisks
indicate statistically signiﬁcant changes among WT and Mecp2−/y slices
(*P < 0.05). (C) STP and LTP were less intense in Mecp2−/y slices. Trolox
improved both types of plasticity in Mecp2−/y slices and LTP recovered to
levels seen in untreated WT slices. In WT, Trolox dampened the extent of
LTP to conditions typically found in untreated Mecp2−/y slices. Averages of
9–12 slices are shown. Error bars are included for every second data point
of WT and Mecp2−/y slices only. LTP was induced by three consecutive
trains of 100 Hz stimuli, lasting 1 s each (see arrow marks). (D) Comparison
of the extent STP and LTP induced in the different groups. The number of
slices analyzed is indicated at the bottom of the bars. Asterisks indicate
statistically signiﬁcant changes as compared to WT (**P < 0.01). (E)
Sample traces of fEPSPs recorded for both genotypes in ACSF under
baseline conditions, immediately after the 3rd high-frequency stimulation
(STP), and 1 h after inducing potentiation (LTP). Stimulus artifacts are
truncated.
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various types of synaptic modulation. Synaptic short-term plas-
ticity was assessed as PPF based on twin-pulse stimulation
(Figure 1B). Stimulation intensity was adjusted to evoke half-
maximum response amplitudes and the interpulse-interval was
varied between 25 and 200ms.Whereas this potentiated the ampli-
tude of the 2nd fEPSP in WT slices to 184.0 ± 34.4% (n = 52) of
control, Mecp2−/y slices showed a signiﬁcantly less pronounced
fEPSP facilitation to only 165.9 ± 35.7% (n = 35; P = 0.020)
for the shortest interpulse interval tested (25 ms, Figure 1B).
Trolox treatment abolished this moderate genotypic difference in
short-term plasticity at the 25 ms interval, but otherwise did not
induce any signiﬁcant changes inWT (n= 47) and Mecp2−/y slices
(n = 39).
Furthermore, we assessed the modulation of short-term poten-
tiation (STP) and LTP by Trolox. STP and LTP were induced by
high-frequency stimulation (Figure 1C). Right after the 3rd stim-
ulus train, fEPSPs were potentiated to 238.2 ± 62.1% (n = 12)
of their baseline amplitudes in WT slices, but in Mecp2−/y the
extent of STP averaged only 158.7 ± 38.0% (n = 11, P = 0.001).
One hour after LTP induction (range 50–60 min), fEPSPs were
still potentiated to 179.4 ± 31.0% in WT slices, but showed a less
intense degree of LTP in Mecp2−/y (143.3 ± 18.5%, P = 0.006;
Figures 1C–E).
Trolox treatment improved the extent of both, STP and LTP in
Mecp2−/y slices. After the 3rd stimulus train fEPSPs were potenti-
ated to 199.3 ± 35.2% and after 1 h they measured 181.1 ± 32.2%
(n = 10). In WT, a stimulating effect of Trolox was not observed.
Instead, the extent of STP slightly declined to 172.4 ± 53.7%
(n = 9, P = 0.020) and LTP showed a tendency of being some-
what less pronounced in the presence of Trolox (155.8 ± 33.2%,
P = 0.102; Figures 1C–E) than in untreated WT slices.
ANTICONVULSIVE POTENTIAL OF TROLOX
Rett patients show an increased incidence of epileptic seizures
(Hagberg et al., 1983; Steffenburg et al., 2001) and increased
neuronal excitability is also evident in MeCP2-deﬁcient mice
(Medrihan et al., 2008; Fischer et al., 2009; Calfa et al., 2011;
McLeod et al., 2013; Toloe et al., 2014). Since the Trolox-mediated
decrease in fEPSP/ﬁber-volley ratio in Mecp2−/y slices conﬁrms
successful dampening of neuronal hyperexcitability, we also tested
for potential anticonvulsive effects of this free radical scavenger.
Seizure activity was provoked by 4-AP (Rutecki et al., 1987),
and the resulting SLEs were recorded extracellularly in st. pyra-
midale of the CA3 subﬁeld, as hyperexcitability in Rett mouse
hippocampus arises particularly in this region (Calfa et al., 2011).
In about two-thirds of the slices tested, 4-AP (100 μM, 35 min
treatment) triggered SLEs which discharged at frequencies of 20–
27/min (Figure 2A). In WT, SLEs arose within 9.3 ± 2.1 min of
4-AP application and during the last 5 min of treatment, an aver-
age number of 135.5 ± 87.3 discharges occurred. The duration of
the individual SLEs was quite variable, averaging 362 ± 255 ms
(n = 11, Figures 2B,C). In Mecp2−/y slices, similar parame-
ters were recorded; SLEs started within 9.2 ± 2.3 min of 4-AP
treatment and 105.3 ± 77.8 discharges were registered during the
last 5 min; the individual SLEs exhibited an average duration of
429 ± 193 ms (n = 12; Figures 2B,C). Trolox treatment (1 mM,
3–5 h) showed a solid tendency to postpone the onset of SLEs in
WT slices only (n = 11, P = 0.058); the frequency of discharges
was not signiﬁcantly affected (Figure 2B). Also the duration of the
individual SLEs only showed a tendency to decrease upon Trolox
treatment in both WT (n = 11) and Mecp2−/y slices (n = 9), yet
the level of signiﬁcance was not reached (Figure 2C).
TROLOX TREATMENT NORMALIZES THE HYPOXIA SUSCEPTIBILITY
Previously we reported that MeCP2-deﬁcient hippocampus shows
an increased susceptibility to hypoxia. As a consequence, the onset
of the synchronized response to severe hypoxia – known as HSD –
is signiﬁcantly hastened in adult Mecp2−/y hippocampal slices.
Accordingly, MeCP2-deﬁcient neurons tolerate only a shorter
duration of O2 shortage and/or chemically induced anoxia before
neuronalmembrane potentials collapse andneural function ceases
(Fischer et al., 2009; Kron and Müller, 2010).
For a comparison of hypoxic responses, HSD was induced in
WT and Mecp2−/y slices with and without Trolox treatment. Sim-
ilar to what was seen earlier, untreated Mecp2−/y slices generated
HSD within 1.8 ± 0.5 min upon O2 withdrawal (n = 32), i.e., 28%
earlier than WT slices in which HSD occurred after 2.5 ± 0.8 min
of severe hypoxia (n = 37, P < 0.001; Figure 3A). The amplitude
and duration of the HSD-associated extracellular DC potential
shift did not differ among genotypes (Figure 3B). Upon Trolox
treatment (1 mM,3–5 h; Trolox recirculated in the interface cham-
ber) HSD occurred markedly delayed in Mecp2−/y slices, i.e., after
2.5 ± 0.7 min (n = 36, P < 0.001), and its time to onset did no
longer differ fromWT slices. Interestingly, inWT slices, Trolox did
not postpone the occurrence of HSD (n = 37; Figure 3).
MODULATION OF MITOCHONDRIAL FUNCTION
To decide whether Trolox also modulates mitochondrial func-
tion, we assessed mitochondrial metabolism by imaging FAD and
NADH autoﬂuorescence (Duchen and Biscoe, 1992; Hepp et al.,
2005; Foster et al., 2006), and mitochondrial membrane poten-
tial (m) by recording Rh123 ﬂuorescence (Emaus et al., 1986;
Duchen, 1999). These imaging experiments were performed on
the tissue level in st. radiatum of the CA1 subﬁeld (see Figure 4D),
as also synaptic function was analyzed in this very layer.
As we reported earlier, the ratio of FAD/NADH autoﬂuo-
rescence is slightly increased (i.e., more oxidized) in Mecp2−/y
hippocampus, indicating an intensiﬁed basal mitochondrial res-
piration (Großer et al., 2012). Also in the current experiments, the
FAD/NADH ratio was increased slightly by an average of 10.9%
in Mecp2−/y slices (n = 17, P = 0.011) as compared to WT
(n = 19; Figures 4A,B). Trolox (1 mM, 3–5 h) did not mediate any
statistically signiﬁcant changes in these metabolic parameters of
eitherWT or Mecp2−/y slices; the observed fading of the moderate
genotypic differences in FAD/NADH ratio (Figure 4B) therefore
seems to arise from data variability rather than a deﬁned effect of
Trolox.
In addition to basal metabolism we also deﬁned the impact
of pharmacological inhibition of the respiratory chain. Applica-
tion of low and high doses of CN− (100 μM, 1 mM), caused the
expected dose-dependent decreases in FAD/NADH ratio (up to
−29.9 ± 2.5%, n = 19 in WT; up to −30.8 ± 2.6%, n = 17 in
Mecp2−/y), which were indistinguishable among untreated slices
(Figures 4A,C). Trolox (1 mM, 3–5 h) slightly but signiﬁcantly
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FIGURE 2 |Trolox only shows a general tendency to dampen seizure
susceptibility. (A) Seizure-like discharges (SLEs) recorded from an untreated
Mecp2−/y slice in CA3 st. pyramidale. The lower trace shows a SLE (red box)
at a stretched time scale. (B) Summary of the times to onset and the number
of SLEs recorded in the two genotypes. Only in WTTrolox tended to
postpone the onset of discharges as compared to untreated slices. The
number of slices analyzed is indicated and applies to panel C as well. (C)
Statistically signiﬁcant differences in the duration of the individual SLEs
among the genotypes were not observed. Trolox only tended to somewhat
reduce the duration of the individual discharges in WT and Mecp2−/y slices.
dampened the inhibitory effects of both low (P = 0.008) and high
(P = 0.021) CN− concentrations in Mecp2−/y slices, by an average
of 13.5 and 10.1%, respectively (n = 19, Figure 4C), suggesting
that it may reduce the susceptibility of mitochondrial metabolism
against (chemical) anoxia. In WT slices, such dampening effects
of Trolox did not occur (n = 15).
Our earlier experiments also suggested a partly depolarized
m in Mecp2−/y hippocampus (Großer et al., 2012). Per-
forming corresponding experiments conﬁrmed less intense m
responses in Mecp2−/y slices (n = 20, P = 0.030) upon mito-
chondrial uncoupling by 5 μM FCCP than in WT (n = 20;
Figures 4E,F), and hence a less negative m. Upon Trolox treat-
ment, both WT (n = 15) and Mecp2−/y slices (n = 17) tended
to show slightly more intense Rh123 responses to FCCP; as a
result, the genotypic difference became smaller and was no longer
statistically signiﬁcant (Figure 4F).
Cyanide-mediated inhibition of mitochondrial respiration
evoked marked increases in Rh123 ﬂuorescence, indicating strong
mitochondrial depolarization (Figures 4E,G). For better compa-
rability, these Rh123 changes were normalized to the complete
mitochondrial depolarization induced by FCCP. Genotypic dif-
ferences were, however, not observed in the responses of WT
and Mecp2−/y slices to low and high CN− doses (n = 20 each;
Figure 4G). Neither did Trolox signiﬁcantly modulate the extent
of the CN−-induced mitochondrial depolarization. Only in the
case of high CN− concentrations, the Rh123 responses tended
to be slightly higher in Trolox-treated Mecp2−/y slices (n = 17,
P = 0.059).
DISCUSSION
Presently, there is no cure for RS, but a number of pharma-
cotherapeutic strategies ameliorate certain aspects of the complex
clinical presentation [see: (Chapleau et al., 2013)]. Some of these
treatments aim to prevent oxidative stress by improving cellular
redox balance. Curcumine-feeding of female Rett mice dampens
the intensiﬁed ROS generation in mesenteric artery and reinstates
normal vasculature function (Panighini et al., 2013). Initial veriﬁ-
cation of antioxidant treatment in Rett patients conﬁrms that oral
supplementationwithω-3 polyunsaturated fatty acids successfully
decreases the clinical severity score by improving motor function,
non-verbal communication and breathing (De Felice et al., 2012a).
Here we analyzed to what degree the radical scavenger Trolox
ameliorates neuronal function in the MeCP2-deﬁcient mouse hip-
pocampal network. Our choice of a vitamin E derivative was
based on the high scavenging efﬁciency of this class of com-
pounds, and Trolox in particular was selected due to its water
solubility. Vitamin E derivatives outrun any destructive interac-
tions of hydroperoxyl radicals with polyunsaturated fatty acids by
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FIGURE 3 |Trolox improves the hypoxia tolerance of Mecp2−/y
hippocampus. (A) Extracellular DC potential deﬂections associated with
HSD. Note that upon O2 withdrawal, HSD occurs earlier in Mecp2−/y than
in WT slices. Incubation of slices with Trolox (1 mM, 3–5 h) selectively
postponed HSD onset in Mecp2−/y slices to values typically observed in
WT.The time point of O2 withdrawal is indicated by the arrows; oxygenation
was restored 30 s upon HSD onset. Recordings were performed in CA1 st.
radiatum. (B) Statistical comparison of the characteristic parameters of the
HSD-associated DC potential shift, i.e., amplitude of the negative DC shift
(plotted versus the left-hand ordinate in mV) as well as its time to onset and
duration (both plotted versus the right-hand ordinate in s). Trolox postponed
the onset of HSD in Mecp2−/y slices, but did not affect the other
parameters or its properties in WT. The number of slices analyzed is
reported; genotypic differences are indicated by asterisks (***P < 0.001).
scavenging these radicals at∼1.000-fold faster kinetics and thereby
break lipid peroxidation chain reactions (Buettner, 1993; Traber
and Stevens, 2011; Alberto et al., 2013). Furthermore, they also
reactwith singlet oxygen aswell as superoxide, anddecrease the cell
endogenous H2O2 formation (Brigelius-Flohé and Traber, 1999;
Peus et al., 2001). Most importantly, vitamin E is not degraded in
the scavenging process but is rather “recycled” to its reduced state
by, e.g., vitamin C (Buettner, 1993; Traber and Stevens, 2011),
which further optimizes its efﬁciency.
Indeed, in isolated tissue of already symptomatic Rett mice,
acute 3–5 h Trolox treatment clearly dampened neuronal hyper-
excitability, improved synaptic plasticity, and increased the tol-
erance to severe hypoxia. As shown previously this free radical
scavenger also decreases the elevated (more oxidized) redox base-
lines in Mecp2−/y hippocampal slice cultures and dampens the
exaggerated redox responses to oxidant challenge (Großer et al.,
2012). Less clear effects of Trolox were, however, observed on
mitochondria and seizure-like activity.
In detail, in the hippocampal network, Trolox improved basal
synaptic function by selectively dampening neuronal hyperex-
citability in Mecp2−/y but not in WT slices. As a result, the
normalized fEPSPs reached amplitudes typical of untreated WT
slices. Mechanistically, a modulation of neuronal network func-
tion by changes in cellular redox balance is difﬁcult to predict, since
various pivotal ion-channels and transmitter receptors are mod-
ulated to different degrees and may even respond oppositely. For
example oxidant challenge blocks NMDA and GABAA receptors
(Aizenman et al., 1989; Sah et al., 2002) but activates voltage-gated
Na+ channels and ryanodine receptors (Hammarström and Gage,
2000; Hidalgo et al., 2004; Gerich et al., 2009). Since we did not
perform detailed pharmacological trials, the molecular origin of
hyperexcitability in Mecp2−/y mice is unclear. Yet, independent of
itsmechanism, thenormalizationof excitability byTroloxmaywell
be of importance in view of the pronounced seizure susceptibility
associated with RS and it may also contribute to the postponed
onset of HSD in Trolox-treated Mecp2−/y slices.
Trolox also improved various aspects of synaptic plasticity
which is an important ﬁnding in view of the severe cogni-
tive impairment in RS. PPF was not primarily affected, but the
genotypic differences among WT and Mecp2−/y slices under
control conditions, were no longer present upon Trolox treat-
ment. More importantly the extent of STP was improved by
Trolox and LTP was fully restored to its normal extent. As
especially long-term plasticity improved, it seems that in par-
ticular postsynaptic structures were modulated by the radical
scavenger treatment. LTP induction at Schaffer collateral/CA1
synapses is NMDA-receptor dependent (Bliss and Collingridge,
1993). It is therefore tempting to speculate that the more oxi-
dizing conditions in Mecp2−/y hippocampus partially inactivate
the oxidation-sensitive NMDA receptors (Aizenman et al., 1989)
and thus contribute to the less stable LTP seen in Rett mouse
hippocampus (Asaka et al., 2006; Moretti et al., 2006; Guy et al.,
2007). Along this line, theTrolox-mediatednormalizationof redox
balance may have restored normal NMDA receptor function and
thus LTP.
In WT slices, however, the extent of STP was dampened by
Trolox and also LTP tended to be depressed. In this aspect the
modulation of synaptic plasticity by Trolox differs from its effects
on basal synaptic function, where no effects onWT were observed.
A reasonable explanation for these ﬁndings is the strict dependence
of LTP on exact cellular redox balance. Oxidant stress may inter-
fere with LTP maintenance without affecting STP or PPF (Pellmar
et al., 1991). Yet, also reducing shifts due to overexpression of
extracellular SOD3 or administration of superoxide scavengers
impair hippocampal LTP (Klann et al., 1998; Thiels et al., 2000).
It therefore seems that ROS do not only oppose the induction of
stable LTP but to some degree are essential for synaptic plastic-
ity (Massaad and Klann, 2011). This emphasizes the importance
of a well-balanced cellular redox equilibrium and hence opti-
mized dosage of redox-modulators such as radical scavengers. We
tested only a single concentration of Trolox (1 mM), and observed
improved LTP in Mecp2−/y slices, but its partial depression inWT.
Accordingly, a more careful titration of redox conditions may be
required to ensure that LTP improves in Mecp2−/y slices without
dampening synaptic plasticity in WT.
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FIGURE 4 |Trolox only slightly affects mitochondria. (A) Sample traces of
the decreases in FAD/NADH ratio induced by CN− in untreated WT and
Mecp2−/y slices. To clarify the baseline difference among genotypes, the
traces were superimposed. Gray and red bars indicate the time points and
duration of drug application to the WT and Mecp2−/y slice, respectively. (B)
The FAD/NADH baseline ratio is moderately increased in Mecp2−/y slices,
indicating intensiﬁed mitochondrial respiration. Trolox (1 mM, 3–5 h) did not
(Continued)
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FIGURE 4 | Continued
affect basal respiration. Autoﬂuorescence was analyzed in CA1 st. radiatum.
Bar shading and patterns are identical for panels B, C, F (*P < 0.05). (C)
Mitochondrial targeting by CN− (3 min) arrests the respiratory chain, and
thereby decreases the FAD/NADH ratio. Trolox slightly dampened these
effects of CN− in Mecp2−/y slices but not in WT (** P < 0.01). (D)
Rh123-labeled slice viewed under white-light illumination and 485 nm
excitation. The overview image was taken with a 5x objective, and it also
shows two of the vertical-oriented nylon strings immobilizing the slice. The
red box indicates the zoomed ﬁeld of view used for the Rh123 recordings.
Fluorescence analyses were performed with a 40x objective and represent
an integrated glial/neuronal signal of a tissue volume. Cell boundaries or
mitochondrial structures are not identiﬁable, only the pyramidal cell layer is
somewhat less intensely labeled. The white box indicates a typical region of
interest analyzed (so st. oriens; sp st. pyramidale; sr st. radiatum). (E)
Superimposed sample traces of the relative Rh123 ﬂuorescence changes
(F/Fo ) evoked by CN− and FCCP in aTrolox-treated WT and Mecp2−/y slice.
Drug treatment of the WT and Mecp2−/y slice is indicated by gray and red
bars, respectively. (F) Uncoupling-mediated increases in Rh123
ﬂuorescence indicating massive mitochondrial depolarization. Untreated
Mecp2−/y slices showed less pronounced Rh123 increases upon FCCP
treatment (5 μM, 5 min), suggesting a less negative m Trolox dampened
this genotypic difference. Data were analyzed in CA1 st. radiatum. (G)
Summary of the CN−-evoked increases in Rh123 ﬂuorescence. Plotted data
are normalized to the respective effects of FCCP, i.e., the maximum
depolarization induced at the end of the experiment in each slice.
Despite a selective dampening of neuronal excitability in
Mecp2−/y slices by Trolox, we did not observe a marked reduc-
tion in seizure susceptibility. Only in WT, the onset of SLEs
tended to be postponed and the duration of the individual
SLEs only tended to be decreased by Trolox in both WT and
Mecp2−/y slices. Even though the latter occurred in both geno-
types, it may be of some proﬁt by dampening the severity
of seizures once such abnormal discharges are triggered. It
should be considered, however, that the K+ channel inhibitor
4-AP is a rather strong convulsive stimulus. Nevertheless, as
a pronounced seizure susceptibility is associated with RS, and
even constitutes a potential cause for sudden death (Hagberg
et al., 1983; Steffenburg et al., 2001), it is an important ﬁnding
that the Trolox-mediated normalization of synaptic plasticity in
Mecp2−/y hippocampus is not associated with negative side effects
such as increased neuronal excitability and/or increased seizure
susceptibility.
Trolox also abolished the increased susceptibility of Mecp2−/y
hippocampus to the lack of O2. The hastened onset of HSD in
Mecp2−/y slices was selectively reverted toWTconditions, whereas
WT slices were not affected. Hence, the normalized hypoxia sus-
ceptibility constitutes another protective effect that was induced
by Trolox selectively in Mecp2−/y slices. Treatments decreasing
neuronal excitability postpone the onset of spreading depression
while increased excitability favors its occurrence [see (Somjen,
2001)]. Therefore, the postponement of HSD in Mecp2−/y slices
by Trolox is very likely a result of the observed selective damp-
ening of neuronal excitability, i.e., fEPSP/ﬁber volley ratios. In
contrast, Trolox-treated WT slices did not show any alterations
in neuronal excitability nor HSD onset. Also increased ROS lev-
els (Grinberg et al., 2012), changes in thiol redox balance (Hepp
et al., 2005; Hepp and Müller, 2008), and mitochondrial inhi-
bition (Gerich et al., 2006) modulate the induction threshold
of spreading depression. Hence, the postponement of HSD in
Trolox-treated Mecp2−/y slices may also partly be due to the
stabilized redox balance or a slightly improved mitochondrial
anoxia tolerance that is suggested by the milder CN− effects in
Trolox-treated Mecp2−/y slices. In view of the highly irregular
breathing and the associated intermittent systemic hypoxia in RS
(Julu et al., 2001; Stettner et al., 2008; Katz et al., 2009), the Trolox-
mediated increase in hypoxia tolerance is clearly of potentialmerit,
as it may prevent additional complications especially in anoxia
vulnerable neuronal networks such as the hippocampus and
cortex.
Mitochondria are a primary cellular source of ROS (Boveris and
Chance, 1973; Adam-Vizi, 2005), and mitochondrial alterations in
RS underlie the increased oxidative burden and altered cellular
redox homeostasis (Großer et al., 2012). However, mitochondria
are also potential targets for oxidative damage, and respond with
morphological and functional changes including altered intra-
cellular trafﬁcking (Petronilli et al., 1994; Gerich et al., 2009; Qi
et al., 2011; Lenaz and Genova, 2012). We therefore screened
whether Trolox may modulate mitochondrial function directly,
but a noticeable improvement of mitochondrial function was not
observed. The genotypic baseline differences in FAD/NADH ratio
were not signiﬁcantly affected by Trolox. During 1 mM CN−
treatment, it mediated only a moderate dampening effect on the
anoxic drop in FAD/NADH ratio, which may suggest an increased
anoxia tolerance of mitochondrial respiration, yet any correspond-
ing effects on m were not observed. Also the trend to slightly
increased Rh123 responses in both WT and Mecp2−/y slices dur-
ing uncoupling or the tendency of somewhat increased Rh123
responses to high CN− concentrations in Mecp2−/y slices may
suggest some improvement of m, but as stated, the level of
signiﬁcance was not reached. It therefore seems that the protective
effects of vitamin E reported for rat liver mitochondria, i.e., partial
normalization of the increased state 3 and state 4 respiration upon
acute lipid peroxidation (Ham and Liebler, 1997), do not apply to
hippocampal mitochondria and the chronic oxidative stress asso-
ciated with RS. Yet, at least our data conﬁrm that Trolox does not
mediate any adverse side effects on mitochondrial function in WT
and especially in Mecp2−/y slices.
CONCLUSION
The free radical scavenger treatment performed in our study
veriﬁes the potential merit of Trolox for targeting the aberrant
redox conditions that manifest in MeCP2-deﬁcient networks. In
isolated Mecp2−/y hippocampal tissue of symptomatic mice we
conﬁrmed an improvement of various aspects of neuronal net-
work function, including synaptic plasticity, neuronal excitability,
and hypoxia tolerance. At the same time we ruled out poten-
tially adverse side effects onmitochondrialmetabolism and seizure
susceptibility.
Of course, the hippocampus shows a tight coupling of neural
function, metabolism and cellular redox balance, as it is highly
vulnerable (Schmidt-Kastner and Freund, 1991), exhibits a clear
basal ROS production (Bindokas et al., 1996) and its CA1 neu-
rons are particularly sensitive to oxidative stress (Wilde et al.,
1997; Wang et al., 2007). Therefore, Trolox now should undergo
further detailed tests to clarify, how other, less vulnerable brain
areas respond to radical scavengers and/or modulation of cellular
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redox homeostasis. This should also include more complex prepa-
rations up to in vivo treatment of Rett mice to carefully deﬁne
the merits but also limitations of these compounds. In RS mito-
chondrial dysfunction and redox imbalance manifest early in life,
and may contribute to disease progression. It is therefore crucial
to start radical scavenger treatment at presymptomatic stages to
deﬁne potential changes in disease progression and the manifes-
tation of typical symptoms. Only then, these compounds may
unveil their full pharmacotherapeutic potential for the treatment
of RS.
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